[Treatment of arteriosclerosis obliterans of the legs with continuous intraarterial medication].
D001161:Arteriosclerosis; D001162:Arteriosclerosis Obliterans; D003850:Deoxyribonuclease I; D007866:Leg; D011343:Procaine / Q000627:therapeutic use*; D013299:Streptodornase and Streptokinase / Q000627:therapeutic use*; D013300:Streptokinase
D011343:Procaine; D013299:Streptodornase and Streptokinase; D003850:Deoxyribonuclease I; D013300:Streptokinase
ARTERIOSCLEROSIS; PROCAINE/therapeutic use; STREPTODORNASE AND STREPTOKINASE/therapeutic use
Tratamiento de la arteriosclerosis obliterante de los miembros inferiores con la medicación continuada intraarterial.